Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway

被引:86
作者
Paz, S.
Sun, Q.
Nakhaei, P.
Romieu-Mourez, R.
Goubau, D.
Julkunen, I.
Lin, R.
Hiscott, J.
机构
[1] Lady Davis Inst Med Res, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada
[3] McGill Univ, Dept Med, Montreal, PQ, Canada
[4] Univ Helsinki, Helsinki, Finland
[5] Natl Publ Hlth Inst, Helsinki, Finland
关键词
interferon signaling; RIG-O; innate immunity; antiviral response;
D O I
10.1170/T694
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The induction of type I interferon (IFN) and the development of the innate antiviral response are mediated by the activation of interferon regulatory factor (IRF)-3 and IRF-7 under the control of the non-canonical kinases TBK-1 and IKK epsilon. The initial sensing of infection by RNA viruses is mediated by the cytoplasmic, retinoic acid inducible gene I (RIG-I), via a Toll-like receptor (TLR) independent signaling pathway. In the present study, we identify key residues involved in IRF-3 and IRF-7 phosphorylation using TAO-tag purification of TBK-1 and IKK epsilon proteins. Based on the identification of an extended lsequence motif - SxSxxxS - common to both IRF-3 and IRF-7, an IRF-7 pSer477/479 phosphospecific antibody was generated. Virus infection, TBK-1/IKK epsilon expression or co-expression of different signaling adaptors such as RIG-I MAVS and TRIF, all stimulated pSer477/479 phosphorylation. Furthermore, the newly identified adaptor of the RIG-I pathway (MAVS/IPS-1/VISA/Cardif) was able to induce IRF and NF-kappa B (dependent promoter activity as efficiently as the constitutively active form of RIG-I (Delta RIG-1). Co-expression of the NS3/4A protease activity of hepatitis) virus however blocked MAVS-mediated gene activation in a dose dependent manner. These studies link RIG-I sensing of viral RNA to downstream kinase signaling and phosphorylation of IRF-3 and IRF-7 via the MAVS/IPS/VISA/Cardif adaptor.
引用
收藏
页码:17 / 28
页数:12
相关论文
共 50 条
[1]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[2]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[3]   The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter [J].
Andrejeva, J ;
Childs, KS ;
Young, DF ;
Carlos, TS ;
Stock, N ;
Goodbourn, S ;
Randall, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17264-17269
[4]   Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes [J].
Au, WC ;
Moore, PA ;
LaFleur, DW ;
Tombal, B ;
Pitha, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) :29210-29217
[5]   Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKε [J].
Breiman, A ;
Grandvaux, N ;
Lin, RT ;
Ottone, C ;
Akira, S ;
Yoneyama, M ;
Fujita, T ;
Hiscott, J ;
Meurs, EF .
JOURNAL OF VIROLOGY, 2005, 79 (07) :3969-3978
[6]   Plasmacytoid dendritic cells in immunity [J].
Colonna, M ;
Trinchieri, G ;
Liu, YJ .
NATURE IMMUNOLOGY, 2004, 5 (12) :1219-1226
[7]   AN ATF/CREB BINDING-SITE PROTEIN IS REQUIRED FOR VIRUS INDUCTION OF THE HUMAN INTERFERON BETA GENE [J].
DU, W ;
MANIATIS, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) :2150-2154
[8]   IKKε and TBK1 are essential components of the IRF3 signaling pathway [J].
Fitzgerald, KA ;
McWhirter, SM ;
Faia, KL ;
Rowe, DC ;
Latz, E ;
Golenbock, DT ;
Coyle, AJ ;
Liao, SM ;
Maniatis, T .
NATURE IMMUNOLOGY, 2003, 4 (05) :491-496
[9]   LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF [J].
Fitzgerald, KA ;
Rowe, DC ;
Barnes, BJ ;
Caffrey, DR ;
Visintin, A ;
Latz, E ;
Monks, B ;
Pitha, PM ;
Golenbock, DT .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (07) :1043-1055
[10]  
FOY E, 2005, P NATL ACAD SCI USA, V79, P2689